Model Number TFH9100 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Ulcer (2274)
|
Event Date 10/18/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
Novocure's opinion is that a contribution to the event cannot be excluded.Contributing factors for skin ulcer in this patient include: prior radiation, chemotherapy, prior surgery affecting skin integrity.Skin ulcer was reported as an adverse event in the ef-14 trial of optune together with temozolomide (tmz) compared to tmz alone in patients with newly diagnosed gbm in the optune/tmz arm of the trial (<1%) only.
|
|
Event Description
|
A (b)(6) female patient with newly diagnosed glioblastoma began optune therapy on (b)(6) 2019.On (b)(6) 2019, novocure was informed by the prescribing site nurse that during a transducer array exchange on (b)(6) 2019, an open sore was observed on the scalp with exposed cranium hardware (last resection (b)(6) 2019).Prescribing physician instructed the patient to seek treatment at the emergency department for a possible infection associated with the ulceration.No further information on treatment and clinical course was provided.Prescribing physician was contacted for additional information and causality assessment with no response.
|
|
Manufacturer Narrative
|
On december 23, 2021, novocure discovered that the initial submitted medical device report had a typo in the model number for the optune device in section d4-suspect medical device model number.Corrected model number is tfh9100.
|
|
Search Alerts/Recalls
|